[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK106393A - Novel pharmaceutical use of(nva)2-cyclosporine - Google Patents

Novel pharmaceutical use of(nva)2-cyclosporine

Info

Publication number
HK106393A
HK106393A HK106393A HK106393A HK106393A HK 106393 A HK106393 A HK 106393A HK 106393 A HK106393 A HK 106393A HK 106393 A HK106393 A HK 106393A HK 106393 A HK106393 A HK 106393A
Authority
HK
Hong Kong
Prior art keywords
nva
cyclosporine
pharmaceutical use
novel pharmaceutical
novel
Prior art date
Application number
HK106393A
Other languages
English (en)
Inventor
Jean-Francois Borel
Peter Donatsch
Peter Hiestand
Bernhard Ryffel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848419716A external-priority patent/GB8419716D0/en
Priority claimed from GB848419715A external-priority patent/GB8419715D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HK106393A publication Critical patent/HK106393A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK106393A 1984-08-02 1993-10-07 Novel pharmaceutical use of(nva)2-cyclosporine HK106393A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848419716A GB8419716D0 (en) 1984-08-02 1984-08-02 Organic compounds
GB848419715A GB8419715D0 (en) 1984-08-02 1984-08-02 Organic compounds

Publications (1)

Publication Number Publication Date
HK106393A true HK106393A (en) 1993-10-15

Family

ID=26288061

Family Applications (1)

Application Number Title Priority Date Filing Date
HK106393A HK106393A (en) 1984-08-02 1993-10-07 Novel pharmaceutical use of(nva)2-cyclosporine

Country Status (8)

Country Link
EP (2) EP0365044A3 (fr)
AU (1) AU581010B2 (fr)
CY (1) CY1697A (fr)
DE (2) DE3580717D1 (fr)
DK (1) DK348385A (fr)
HK (1) HK106393A (fr)
PH (1) PH21235A (fr)
SG (1) SG17993G (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
WO1989001772A1 (fr) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Composition de cyclosporine oculaire
DE68900991D1 (de) * 1988-01-29 1992-04-23 Sankyo Co Cyclosporin-zusammensetzungen.
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
EP0642332B1 (fr) 1992-05-13 1997-01-15 Sandoz Ltd. Compositions ophtalmiques contenant une cyclosporine
EP0589843B1 (fr) 1992-09-25 2001-11-28 Novartis AG Compositions pharmaceutiques comprenant de la cyclosporine
CA2161143A1 (fr) * 1993-04-20 1994-10-27 Monika Fleck Nouvelles preparations pharmaceutiques renfermant de la cyclosporine, pour administration orale
DK0789580T3 (da) 1994-11-03 2002-09-09 Novartis Ag Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'－脱氧－3'－氧代－MeBmt]'环孢菌素制备方法
KR20040004416A (ko) 1997-01-30 2004-01-13 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
DE10356378A1 (de) * 2003-12-03 2005-06-30 Continental Aktiengesellschaft Verfahren zur Funktionssteuerung eines elektronischen Fahrstabilitätsprogramms für ein Kraftfahrzeug
US8394763B2 (en) 2007-09-26 2013-03-12 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
SE448386B (sv) * 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
PH19156A (en) * 1982-02-01 1986-01-15 Sandoz Ltd Dihydrocyclosporin d in the treatment of multiple sclerosis

Also Published As

Publication number Publication date
EP0365044A2 (fr) 1990-04-25
DE3526545A1 (de) 1986-02-13
DK348385A (da) 1986-02-03
DE3580717D1 (de) 1991-01-10
EP0365044A3 (fr) 1990-08-22
SG17993G (en) 1993-04-16
AU4563185A (en) 1986-02-06
EP0170623A3 (en) 1987-10-28
EP0170623A2 (fr) 1986-02-05
CY1697A (en) 1994-01-14
DK348385D0 (da) 1985-07-31
EP0170623B1 (fr) 1990-11-28
AU581010B2 (en) 1989-02-09
PH21235A (en) 1987-08-21

Similar Documents

Publication Publication Date Title
GB2231265B (en) Therapeutic use of serotonin-antagonists
HK106393A (en) Novel pharmaceutical use of(nva)2-cyclosporine
IL75533A (en) Preparation of heteroaryloxyacetamides
GB8507789D0 (en) Preparation of 2-amino-s-triazines
IL76249A0 (en) Preparation of fluoroformates
GB8727401D0 (en) Preparation of trifluoromethylbenzonitrile
AU585890B2 (en) Pharmaceutical use of somatostatin analogues
IL74168A (en) 1alpha-hydroxyvitamin d2 analogs and pharmaceutical compositions containing them
DE3566540D1 (en) Preparation of fluoropyridines
IL82217A0 (en) Preparation of 1-aryl-5-amino-pyrazoles
GB2196961B (en) Preparation of polyfluoroenolates
GB8520403D0 (en) Preparation of aminolactone
IL76216A0 (en) Preparation of sulphonylisoureas and-thioureas
GB8422162D0 (en) Preparation of alkyfurans
ZA855872B (en) Novel pharmaceutical use of(nva)2-and dihydro-(val)2-cyclosporins
GB8601724D0 (en) Application of tetracyano-quinodimethanes
GB8708603D0 (en) Preparation of()-13-norfaranal
IL75926A0 (en) Somatostatin analogs and pharmaceutical compositions containing them
GB8802972D0 (en) Triperfluoroalkylamines & preparation of same
IL82018A0 (en) Preparation of 4-nitrophenetol
GB8613066D0 (en) Protection of proteins &c
GB8704561D0 (en) Application of tetrathiafulvalenes
IL91357A0 (en) Pharmaceutical formulations containing certain benzimi-azolylmethyl benzenamides
IE840693L (en) Preparation of azinomethyl-rifamycins
IE840895L (en) Preparation of benzothien-3-ylglycines

Legal Events

Date Code Title Description
NR Patent deemed never to have been added to the register under section 13(7) of patents (transitional arrangements) rules